Effect of Solar Salt Diet in Elderly Hypertensive Patients

This study has been completed.
Mokpo National University
the ministry of knowledge economy
Information provided by:
Chung-Ang University Hospital
ClinicalTrials.gov Identifier:
First received: April 8, 2010
Last updated: April 9, 2010
Last verified: March 2010

High sodium intake causes hypertension. Various efforts for reducing salt consumption are proceeding all over the world. Solar salt contains reduced sodium and abundant mineral, such as calcium, potassium, and magnesium, comparing to ordinary salt. Use of solar salt, instead of ordinary salt, may have beneficial effects to blood pressure.

The investigators are going to conduct a preliminary study that can support antihypertensive effect of solar salt intake.

Condition Intervention Phase
Other: ordinary salt based- diet
Phase 3

Study Type: Interventional

Resource links provided by NLM:

Further study details as provided by Chung-Ang University Hospital:

Primary Outcome Measures:
  • Blood pressure

Arms Assigned Interventions
Experimental: solar salt based-diet Other: ordinary salt based- diet


Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

  • above 50 years elderly hypertensive patients
  • possible oral intake

Exclusion Criteria:

  • dementia, GDS>6
  • terminal cancer patient
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01102023

Korea, Republic of
Lohas-clover silver hospital
Seoul, Korea, Republic of
Sponsors and Collaborators
Chung-Ang University Hospital
Mokpo National University
the ministry of knowledge economy
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01102023     History of Changes
Other Study ID Numbers: C2009067(254) 
Study First Received: April 8, 2010
Last Updated: April 9, 2010
Health Authority: Korea: Institutional Review Board

ClinicalTrials.gov processed this record on February 10, 2016